HGF Limited
Andrew Wells is a seasoned professional in intellectual property law and pharmaceutical sciences, currently serving as the Head of the Pharmaceutical Group and Partner at HGF Limited, where tenure began in November 2008. With a robust background, Andrew held the position of Senior Patent Attorney and Team Leader at AstraZeneca from June 2004 to November 2008, focusing on IP due diligence, freedom to operate assessments, and management of global patent portfolios for high-priority drug development projects. Earlier experience includes serving as an Associate at Wilson Gunn, handling patent portfolios in chemical, pharmaceutical, and material science technologies, and a brief tenure as a Formulation Scientist at West Pharmaceutical Services. Andrew holds a PhD in Pharmaceutical Sciences and a Bachelor of Pharmacy, both from the University of Nottingham.
This person is not in any teams
HGF Limited
HGF Ltd is one of Europe’s largest firms of Intellectual Property specialists. The firm is one of only a few to offer a fully integrated IP solution, bringing over 200 patent attorneys, trade mark attorneys, design attorneys, IP solicitors and attorneys-at-law together to provide a full-service IP solution. The firm has 23 offices throughout the UK, Ireland, Germany, Austria, France, The Netherlands and Switzerland. HGF has a strong group of technology-based strategic business units with experience and expertise covering chemistry, engineering, electronics and life sciences. The firm’s multidisciplinary teams of experts include automotive, cleantech, computing and software, energy, food and drink, graphene, medical devices, pharmaceuticals, retail and fashion and healthcare.